Fa Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fa Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Terrence R. Burke
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
2 shared publications Abdul A. Waheed
HIV Drug Resistance Program, National Cancer Institute-Frederick, National Institutes of Health Frederick, MD 21702
1 shared publicationAndrew G. Stephen
Protein Chemistry Laboratory, Advanced Technology Program, SAIC-Frederick, Inc. NCI-Frederick, Frederick, MD 21702
1 shared publicationEric O. Freed
HIV Drug Resistance Program, National Cancer Institute-Frederick, National Institutes of Health Frederick, MD 21702
1 shared publicationJung-Eun Park
Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publicationKyung S. Lee
Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication
Latest Publications
- 1 January 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (1) , 318-321
Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists
- 1 January 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (1) , 318-321
Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists
- 26 September 2009
- Published by Elsevier in Tetrahedron
- Vol. 65 (47) , 9673-9679
Preparation of orthogonally protected (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of polo-box domain-binding peptides
- 26 September 2009
- Published by Elsevier in Tetrahedron
- Vol. 65 (47) , 9673-9679
Preparation of orthogonally protected (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of polo-box domain-binding peptides